Maria E Sundaram
Overview
Explore the profile of Maria E Sundaram including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
2211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang L, Chu L, Sundaram M, Zhou Y, Sun X, Wei Z, et al.
JMIR Public Health Surveill
. 2025 Jan;
11():e63314.
PMID: 39864957
Background: Achieving high vaccine coverage among clinicians is crucial to curb the spread of influenza. Traditional Chinese medicine (TCM), rooted in cultural symbols and concepts without direct parallels in modern...
2.
Bednarczyk R, Sundaram M
Public Health Rep
. 2025 Jan;
:333549241306608.
PMID: 39749889
No abstract available.
3.
Duffy J, Yih W, Walton K, DeSilva M, Glanz J, Hambidge S, et al.
Infection
. 2024 Nov;
PMID: 39565485
Background: The JYNNEOS vaccine (two doses given 28 days apart) was recommended in the United States for people at high risk of exposure to monkeypox virus during the 2022 mpox...
4.
Hechter R, Qian L, Liu I, Sy L, Ryan D, Xu S, et al.
JAMA Netw Open
. 2024 Jun;
7(6):e2415220.
PMID: 38842808
Importance: People with HIV (PWH) may be at increased risk for severe outcomes with COVID-19 illness compared with people without HIV. Little is known about COVID-19 vaccination coverage and factors...
5.
Chung H, Campitelli M, Buchan S, Campigotto A, Crowcroft N, Gubbay J, et al.
Euro Surveill
. 2024 Feb;
29(8).
PMID: 38390652
BackgroundWaning immunity from seasonal influenza vaccination can cause suboptimal protection during peak influenza activity. However, vaccine effectiveness studies assessing waning immunity using vaccinated and unvaccinated individuals are subject to biases.AimWe...
6.
Grima A, Kwong J, Richard L, Reid J, Raphael J, Basta N, et al.
Vaccine
. 2024 Feb;
42(7):1498-1505.
PMID: 38341288
Background: Immune checkpoint inhibitor (ICI) therapy for patients undergoing cancer treatment carries a risk of severe immune-related adverse events (IRAEs). Questions remain about whether seasonal influenza vaccination might increase the...
7.
Polter E, Christianson B, Steinberg A, Doan M, Ljungman H, Sundaram M, et al.
Hum Vaccin Immunother
. 2023 Dec;
19(3):2291859.
PMID: 38095606
Human papillomavirus (HPV) vaccination can dramatically reduce the incidence of HPV-associated cancers. However, HPV vaccination coverage in rural areas is lower than in urban areas, and overall HPV vaccination coverage...
8.
Antonova L, Somayaji C, Cameron J, Sirski M, Sundaram M, McDonald J, et al.
PLoS One
. 2023 Aug;
18(8):e0289292.
PMID: 37611032
Background: The effects of the COVID-19 pandemic have been more pronounced for socially disadvantaged populations. We sought to determine how access to SARS-CoV-2 testing and the likelihood of testing positive...
9.
Werbel W, Weld E, Advani S, Patel P, Sundaram M, Phadke V
Clin Infect Dis
. 2023 Mar;
77(1):32-37.
PMID: 36999905
Mutations accumulated by novel Severe Acute Respiratory Syndrome Coronavirus 2 Omicron sublineages contribute to evasion of previously effective monoclonal antibodies for treatment or prevention of Coronavirus Disease 2019 (COVID-19). Other...
10.
Sundaram M, Kieke B, Hanson K, Belongia E, Weintraub E, Daley M, et al.
Hum Vaccin Immunother
. 2022 Dec;
18(7):2159215.
PMID: 36577134
The safety of 9-valent HPV vaccine (9vHPV) has been established with regard to common and uncommon adverse events. However, investigation of rare and severe adverse events requires extended study periods...